Related Experiment Video
Updated: Jun 22, 2026
09:01
Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach
Published on: June 5, 2010
[Neuromuscular blockers in Brazil.]
Maria Cristina Simões de Almeida1
1Universidade Johannes Gutenberg, Alemanha.
Revista Brasileira De Anestesiologia
|May 28, 2009
Summary
Atracurium is the preferred neuromuscular blocker in Brazil, though succinylcholine sees frequent use in non-emergency cases. Neuromuscular monitors are rarely used, with most anesthesiologists relying on clinical signs for recovery, leading to potential complications.
Area of Science:
- Anesthesiology
- Pharmacology
- Clinical Practice
Context:
- Limited statistical data exists on neuromuscular blocker (NMB) use in Brazil.
- This study addresses the lack of data by surveying Brazilian anesthesiologists.
- The survey was conducted at the 48th Brazilian Congress of Anesthesiology and online.
Purpose:
- To statistically analyze the usage patterns of neuromuscular blockers in Brazil.
- To identify preferred NMBs, indications for specific agents like succinylcholine, and monitoring practices.
- To document the incidence and types of NMB-related complications.
Summary:
- Atracurium is the most frequently used NMB, followed by pancuronium and succinylcholine.
- Succinylcholine is often used for rapid sequence induction and in pediatric patients.
- Neuromuscular transmission monitors are seldom used; clinical signs are the primary recovery criteria, and approximately 30% of complications were reported.
Impact:
- Highlights prevalent NMB choices and practices among Brazilian anesthesiologists.
- Reveals underutilization of neuromuscular monitoring and reliance on clinical criteria.
- Identifies a significant rate of NMB-related complications, emphasizing areas for improved patient safety.
Related Concept Videos
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
01:28Classification of Skeletal Muscle Relaxants
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
01:11Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
01:29Neuromuscular Junction And Blockade
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
01:28Drugs Acting on Autonomic Ganglia: Blockers
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups: